A role of MRI-Ultrasound fusion targeted biopsy of prostate in the diagnosis of prostate cancer
- Авторлар: Shestopalova O.Y.1, Jakovenko A.A1, Rumyantsev A.S.1, Matveev A.V1, Nevirovich E.S1
-
Мекемелер:
- Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
- Шығарылым: № 1 (2019)
- Беттер: 73-77
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/296461
- DOI: https://doi.org/10.18565/urology.2019.16.73-77
- ID: 296461
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
O. Shestopalova
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
Email: shestopalova_ole@mail.ru
radiologist at the Department of X-Ray Computer Tomography № 2
A. Jakovenko
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
Email: leptin-rulit@mail.ru
Ph.D., assistant professor at the Department of Nephrology and Dialysis
A. Rumyantsev
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
Email: rash.56@mail.ru
MD, professor at the Department of internal disease propaedeutic
A. Matveev
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russiaurologist at the Department of Oncology №6 (andrology and oncourology)
E. Nevirovich
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
Email: enevirovich@yahoo.com
Ph.D., Head of the Department of Oncology №6 (andrology and oncourology)
Әдебиет тізімі
- Siegel R., Naishadman D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013;63(1):11-30. doi: 10.3322/caac.21166.
- Аль-Шукри C.X., Боровец С.Ю. Рак предстательной железы: некоторые аспекты эпидемиологии, этиологии и канцерогенеза (обзор литературы). Урологические ведомости. 2012;2(1):23-25
- Чиссов В. И., Русаков И. Г. Заболеваемость раком предстательной железы в Российской Федерации. Экспериментальная и клиническая урология. 2011; 2-3: 6-7
- Аль-Шукри С.Х., Боровец С.Ю., Рыбалов М.А. Ошибки диагностики и стадирования рака предстательной железы. Урологические ведомости. 2013;3(1):23-27
- Hodges K.B., Bachert E., Cheng L. Prostate Cancer Biomarkers: Current Status. Crit Rev Oncog. 2017;22(5-6):253-269. Doi: 10.1615/ CritRevOncog.2017020500.
- Понкратов С.В., Хейфец В.Х., Каган О.Ф. Диагностическая ценность простатспецифического антигена с учетом возраста пациентов. Урологические ведомости. 2016;6(3):30-39). Doi: 10.17816/ uroved6330-39.
- Schroder F.H., Hugosson J., Roobol M.J. et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027-2035. doi: 10.1016/S0140-6736(14)60525-0.
- Bladou F., Fogaing C., Levental M. et al. Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted. Can Urol Assoc J. 2017;11(9):E330-E337. Doi: 10.5489/ cuaj.4308.
- Pepe P., Garufi A., Priolo G., Pennisi M. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA № 10 ng/mL? Clin Genitourin Cancer. 2015;13(1):27-30. doi: 10.1016/j.clgc.2014.06.013.
- Scheltema M.J., Tay K.J., Postema A.W. et al. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol. 2017;35(5):695-701. doi: 10.1007/s00345-016-1932-1.
- Wysock J.S., Rosenkrantz A.B., Huang W.C. et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol. 2013;66:343-351. Doi: 10.1016/j. eururo.2013.10.048.
Қосымша файлдар
![](/img/style/loading.gif)